The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.
Name:
journal.pone.0206007 (1).pdf
Size:
2.013Mb
Format:
PDF
Description:
Full text open access article
Authors
Lamarca, AngelaGaldy, Salvatore
Barriuso, Jorge
Moghadam, Sharzad
Beckett, Elizabeth
Rogan, Jane
Backen, Alison C
Billington, Catherine
McNamara, Mairéad G
Hubner, Richard A
Cramer, Angela
Valle, Juan W
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United KingdomIssue Date
2018
Metadata
Show full item recordAbstract
Expression of human epidermal growth factor receptor (HER)2 and HER3 have been investigated in small BTC studies using variable scoring systems.Citation
The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers. 2018, 13 (10):e0206007 PLoS ONEJournal
PLoS ONEDOI
10.1371/journal.pone.0206007PubMed ID
30335866Type
ArticleLanguage
enISSN
1932-6203ae974a485f413a2113503eed53cd6c53
10.1371/journal.pone.0206007